Benjamin Meier1, Arthur Schmidt2, Nicolas Glaser2, Alexander Meining3, Benjamin Walter3, Andreas Wannhoff1, Bettina Riecken1, Karel Caca4. 1. Department of Gastroenterology, Klinikum Ludwigsburg, Posilipostraße 4, 71640, Ludwigsburg, Germany. 2. Department of Medicine II, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany. 3. Department of Gastroenterology, University Hospital Ulm, Ulm, Germany. 4. Department of Gastroenterology, Klinikum Ludwigsburg, Posilipostraße 4, 71640, Ludwigsburg, Germany. karel.caca@rkh-kliniken.de.
Abstract
BACKGROUND: Gastric subepithelial tumors (SET) are rare and usually benign. However, up to 13% are malignant. Histology after conventional biopsy often is inconclusive. Surveillance endoscopies are the consequence in the majority of gastric SET cases. For SET arising from deeper layers endoscopic resection (ER) with the standard techniques is difficult and associated with the risk of perforation. The RESET trial further evaluates feasibility, efficacy and safety of clip-assisted endoscopic full-thickness resection (EFTR) for gastric SET using the novel gastric full-thickness-resection device (gFTRD). MATERIALS AND METHODS: The RESET trial was initiated in March 2017 (NCT03096236) and designed as prospective observational multicenter pilot trial. Gastric SET up to 15 mm were included. Primary endpoint was technical success (complete enbloc resection). Secondary endpoints were R0 resection, full-thickness resection, adverse events and recurrency at 3-months follow-up. For resection we used the gFTRD (Ovesco Endoscopy, Tübingen, Germany). RESULTS: 29 patients underwent gastric EFTR. Histology prior EFTR after conventional biopsy could define histological tumor type in only 31.2%. Primary endpoint was reached in 89.7%. Histology of the full-thickness-resection specimen could define histological tumor type in 100%. 76% of all SET could be resected histologically complete (R0) and a full-thickness-resection specimen could be obtained in 65.5%. In 31% periprocedural minor bleeding was observed and managed endoscopically. Follow-up was available in 79.3% (OTSC detachment in 78.3%, OTSC in position in 21.7%). No signs of residual or recurrent tumors were observed after 3 months. CONCLUSION: EFTR of gastric SET with gFTRD is feasible and safe. EFTR allows a definite histological diagnosis (including sufficient risk stratification in case of GIST or NET) in contrast to conventional biopsy. R0-resection is possible in most cases and might obviate the need for further surveillance endoscopies for selected patients.
BACKGROUND:Gastric subepithelial tumors (SET) are rare and usually benign. However, up to 13% are malignant. Histology after conventional biopsy often is inconclusive. Surveillance endoscopies are the consequence in the majority of gastric SET cases. For SET arising from deeper layers endoscopic resection (ER) with the standard techniques is difficult and associated with the risk of perforation. The RESET trial further evaluates feasibility, efficacy and safety of clip-assisted endoscopic full-thickness resection (EFTR) for gastric SET using the novel gastric full-thickness-resection device (gFTRD). MATERIALS AND METHODS: The RESET trial was initiated in March 2017 (NCT03096236) and designed as prospective observational multicenter pilot trial. Gastric SET up to 15 mm were included. Primary endpoint was technical success (complete enbloc resection). Secondary endpoints were R0 resection, full-thickness resection, adverse events and recurrency at 3-months follow-up. For resection we used the gFTRD (Ovesco Endoscopy, Tübingen, Germany). RESULTS: 29 patients underwent gastric EFTR. Histology prior EFTR after conventional biopsy could define histological tumor type in only 31.2%. Primary endpoint was reached in 89.7%. Histology of the full-thickness-resection specimen could define histological tumor type in 100%. 76% of all SET could be resected histologically complete (R0) and a full-thickness-resection specimen could be obtained in 65.5%. In 31% periprocedural minor bleeding was observed and managed endoscopically. Follow-up was available in 79.3% (OTSC detachment in 78.3%, OTSC in position in 21.7%). No signs of residual or recurrent tumors were observed after 3 months. CONCLUSION:EFTR of gastric SET with gFTRD is feasible and safe. EFTR allows a definite histological diagnosis (including sufficient risk stratification in case of GIST or NET) in contrast to conventional biopsy. R0-resection is possible in most cases and might obviate the need for further surveillance endoscopies for selected patients.
Authors: Joon Sung Kim; Byung-Wook Kim; Gi Jun Kim; Young Wook Kim; Seung Ji Ryu; Sung Min Park; Jeong-Seon Ji; Sun Young Jun Journal: Surg Endosc Date: 2016-06-28 Impact factor: 4.584
Authors: Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Su Jin Kim; Sun Hwi Hwang; Si Hak Lee Journal: Scand J Gastroenterol Date: 2017-02-28 Impact factor: 2.423
Authors: Arthur Schmidt; Markus Bauder; Bettina Riecken; Daniel von Renteln; Helmut Muehleisen; Karel Caca Journal: Endoscopy Date: 2014-11-07 Impact factor: 10.093
Authors: Arthur Schmidt; Torsten Beyna; Brigitte Schumacher; Alexander Meining; Hans-Juergen Richter-Schrag; Helmut Messmann; Horst Neuhaus; David Albers; Michael Birk; Robert Thimme; Andreas Probst; Martin Faehndrich; Thomas Frieling; Martin Goetz; Bettina Riecken; Karel Caca Journal: Gut Date: 2017-08-10 Impact factor: 23.059
Authors: Tae Won Lim; Cheol Woong Choi; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Su Jin Kim Journal: Medicine (Baltimore) Date: 2016-11 Impact factor: 1.889
Authors: Irmengard Krutzenbichler; Markus Dollhopf; Helmut Diepolder; Andreas Eigler; Martin Fuchs; Simon Herrmann; Gerhard Kleber; Björn Lewerenz; Christoph Kaiser; Tilman Lilje; Timo Rath; Ayman Agha; Francesco Vitali; Claus Schäfer; Wolfgang Schepp; Felix Gundling Journal: Surg Endosc Date: 2020-07-09 Impact factor: 4.584
Authors: Artur Raiter; Katarzyna M Pawlak; Katarzyna Kozłowska-Petriczko; Jan Petriczko; Joanna Szełemej; Anna Wiechowska-Kozłowska Journal: Medicina (Kaunas) Date: 2021-06-16 Impact factor: 2.430